Unveiling the TrkA-p35/CDK5 axis: a novel therapeutic target in diabetic kidney disease. [PDF]
Xia W +10 more
europepmc +1 more source
CYBB-Mediated Ferroptosis Drives Podocyte Injury in Lupus Nephritis and Represents a Therapeutic Target. [PDF]
Wang B +9 more
europepmc +1 more source
Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy. [PDF]
Ke J, Cao L, Zhang S, Xing J.
europepmc +1 more source
Mechanism of microcirculation disturbance in diabetic nephropathy: A review. [PDF]
Tang W, Liu H, Li X, Deng S, Gao C.
europepmc +1 more source
Disruption of Mitochondrial Dynamics and Integrity Drives Divergent Metabolic Flexibility and Resilience in Podocytes. [PDF]
Özel C +13 more
europepmc +1 more source
Hypertension and age-related focal global glomerulosclerosis are associated with biomarkers for cellular senescence. [PDF]
Hughson MD +4 more
europepmc +1 more source
Post‑translational modifications in diabetic kidney disease (Review). [PDF]
He M +8 more
europepmc +1 more source
The effect of SGLT2 inhibitor and HIF-PHI on the podocyte-specific molecules and cytoskeleton of diabetic podocytes. [PDF]
Li C +5 more
europepmc +1 more source
Inhibitory Mechanism of Buyang Huanwu Decoction on AGE/RAGE Pathway in Membranous Nephropathy: Integration of Network Pharmacology and Cell Model Validation. [PDF]
Fu L, Zhang N, Chen X, Xu X, Shen Y.
europepmc +1 more source
Metabolic Crosstalk in Diabetic Kidney Disease: Synergistic Effects of Glucotoxicity and Lipotoxicity. [PDF]
Cao J, Dun Z, Tian D, Qiao Z, Wang Y.
europepmc +1 more source

